Researchers at Tel Aviv University (TAU) have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system of the small and large intestines, bypassing the liver upon systemic administration. They characterize this as a major breakthrough in drug delivery. The groundbreaking study was led by post-doctoral fellow Dr. Riccardo Rampado together with Professor… Read More
A new study from Tel Aviv University (TAU) researchers reveals how bacterial defense mechanisms can be neutralized, enabling the efficient transfer of genetic material between bacteria. The researchers believe this discovery could pave the way for developing tools to address the antibiotic resistance crisis and promote more effective genetic manipulation methods for medical, industrial, and… Read More
Researchers at Tel Aviv University (TAU) have developed a new platform using polymeric nanoparticles to deliver drug pairs to specific cancer types, including skin cancer and breast cancer. The researchers explain that the simultaneous arrival of both drugs at the tumor site together significantly amplifies their therapeutic effects and safety profiles. The study was led… Read More
Professor Ronit Satchi-Fainaro‘s lab at the Faculty of Medical and Health Sciences at Tel Aviv University (TAU) collaborated with Professor Helena Florindo’s lab at the University of Lisbon to produce a novel nano-vaccine for COVID-19. The nano-vaccine, a 200-nanometer particle, trains the immune system against all common COVID-19 variants just as effectively as existing vaccines…. Read More
Researchers at Tel Aviv University (TAU) have determined that the NMDA receptor (NMDAR) in the brain, long studied primarily for its role in learning and memory, also plays a crucial role in stabilizing brain activity. By setting the “baseline” level for activity in neural networks, the NMDAR helps maintain stable brain function amidst continuous environmental… Read More
Researchers at Tel Aviv University (TAU) have found that a variant of the TMEM16F protein, caused by a genetic mutation, enhances the spread of Parkinson’s pathology through nerve cells in the brain. The researchers say that their discovery of a new factor in the pathology of Parkinson’s disease may serve as a target for developing… Read More
Researchers at Tel Aviv University (TAU) and the Sagol Center for Hyperbaric Medicine and Research at the Shamir Medical Center have demonstrated that hyperbaric oxygen therapy (HBOT) improves the condition of PTSD sufferers who have not responded to psychotherapy or psychiatric medications. The researchers say that their unique therapeutic protocol affects the biological brain “wound”… Read More
A technological breakthrough by medical researchers at Tel Aviv University (TAU) enabled the discovery of a cancer mechanism that prevents the immune system from attacking tumors. The researchers were surprised to find that reversing this mechanism stimulates the immune system to fight the cancer cells, even in types of cancer considered resistant to prevailing forms… Read More